Blood Draw Study for Liver Transplant Patients

Immunomonitoring of Transplant Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01525797

Enrollment

221

Registered

2012-02-03

Start date

2002-10-15

Completion date

2013-10-04

Last updated

2026-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Transplant Recipients

Keywords

Liver Transplant

Brief summary

The purpose of this study is to see what a lab test will show and if there is a way to predict which patients will be more likely to have rejection after receiving a liver transplant.

Detailed description

The purpose of this study is simply to see what the new oligonucleotide microarrays will show when comparing the the different patient groups. The results of this study will be one of the first steps In exploring the potential use of this new test.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

17 Years to 65 Years

Healthy volunteers

Yes

Inclusion criteria

* Received a liver Transplant

Exclusion criteria

* Received Multiple Organ Transplant

Design outcomes

Primary

Measure	Time frame	Description
Identify signatures predictive of graft rejection or tolerance.	2 years	Analyze the pattern of gene expression in patients undergoing solid organ transplantation

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORGoran Klintmalm, MD

Baylor Health Care System

Outcome results